E.R.D.E.-AAK-Diagnostik GmbH

E.R.D.E.-AAK-Diagnostik GmbH is an independent, privately funded research and diagnostics laboratory specialised in agonistic autoantibodies against G‑protein-coupled receptors (agAAB). For 25 years, we have focused on these autoantibodies, which target receptors involved in conditions often triggered by viral infections. We hold multiple patents (EU and USA) in the diagnostics and therapy of autoantibody-associated dementia.

The Problem

Agonistic autoantibodies (agAAK) against G‑protein-coupled receptors are a clinically underrecognized driver of serious conditions including Long COVID, Post-Vac Syndrome, ME/CFS, POTS, Alzheimer’s, and vascular dementia. Conventional diagnostics fail to detect these functional autoantibodies, leaving patients without an accurate diagnosis or a targeted therapeutic pathway.

The Solution

E.R.D.E.-AAK-Diagnostik offers testing of patient sera for diverse agonistic autoantibodies using three different validated test systems. For practices, we offer the testing for various agonistic autoantibodies (agAAC) as a service. For patients with positive findings, we provide referrals to expert partners for therapeutic consultation. This enables immunoadsorption the method by which these agonistic autoantibodies can be removed from the body.